{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T18:18:54Z","timestamp":1773339534451,"version":"3.50.1"},"reference-count":43,"publisher":"Elsevier BV","issue":"23","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,4,19]],"date-time":"2018-04-19T00:00:00Z","timestamp":1524096000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014588","name":"Sanofi Pasteur","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014588","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.vaccine.2018.04.050","type":"journal-article","created":{"date-parts":[[2018,4,30]],"date-time":"2018-04-30T06:47:57Z","timestamp":1525070877000},"page":"3345-3350","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Dengue vaccination during pregnancy \u2013 An overview of clinical trials data"],"prefix":"10.1016","volume":"36","author":[{"given":"Anna","family":"Skipetrova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tram Anh","family":"Wartel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophia","family":"Gailhardou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2018.04.050_b0005","series-title":"Dengue haemorrhagic fever: diagnosis, treatment, prevention and control","author":"World Health Organization","year":"1997"},{"key":"10.1016\/j.vaccine.2018.04.050_b0010","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nature12060","article-title":"The global distribution and burden of dengue","volume":"496","author":"Bhatt","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2018.04.050_b0015","unstructured":"World Health Organization. Global strategy for dengue prevention and control: 2012-2020; 2012."},{"key":"10.1016\/j.vaccine.2018.04.050_b0020","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/S0140-6736(14)61060-6","article-title":"Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial","volume":"384","author":"Capeding","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2018.04.050_b0025","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1056\/NEJMoa1411037","article-title":"Efficacy of a tetravalent dengue vaccine in children in Latin America","volume":"372","author":"Villar","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2018.04.050_b0030","unstructured":"World Health Organization. Updated Questions and Answers related to the dengue vaccine Dengvaxia\u00ae and its use. Immunization, Vaccines and Biologicals; 2017."},{"key":"10.1016\/j.vaccine.2018.04.050_b0035","doi-asserted-by":"crossref","first-page":"e2217","DOI":"10.1371\/journal.pntd.0002217","article-title":"Is pregnancy associated with severe dengue? A review of data from the Rio de Janeiro surveillance information system","volume":"7","author":"Machado","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2018.04.050_b0040","doi-asserted-by":"crossref","unstructured":"Paix\u00e3o ES, Teixeira MG, Costa MdCN, Rodrigues LC. Dengue during pregnancy and adverse fetal outcomes: a systematic review and meta-analysis. Lancet Infect Dis 2016.","DOI":"10.1016\/S1473-3099(16)00088-8"},{"key":"10.1016\/j.vaccine.2018.04.050_b0045","doi-asserted-by":"crossref","unstructured":"Ravel G, Rogue A, Sp\u00e9zia F, Forster R, Mantel N, Gould S. Transfer of tetravalent dengue vaccine during gestation and lactation in mice. In: 51st congress of the European societies of toxicology; 2015.","DOI":"10.1016\/j.toxlet.2015.08.783"},{"key":"10.1016\/j.vaccine.2018.04.050_b0050","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.1016\/j.vaccine.2011.03.057","article-title":"Live-attenuated, tetravalent dengue vaccine in children, adolescents and adults in a dengue endemic country: randomized controlled phase I trial in the Philippines","volume":"29","author":"Capeding","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.04.050_b0055","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.4269\/ajtmh.13-0304","article-title":"Immunogenicity and safety of a recombinant tetravalent dengue vaccine in children and adolescents ages 9\u201316 years in Brazil","volume":"89","author":"Dayan","year":"2013","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2018.04.050_b0060","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1080\/21645515.2015.1076598","article-title":"Immunogenicity and safety of a tetravalent dengue vaccine in healthy adults in India: a randomized, observer-blind, placebo-controlled phase II trial","volume":"12","author":"Dubey","year":"2016","journal-title":"Hum Vaccine Immunother"},{"key":"10.1016\/j.vaccine.2018.04.050_b0065","doi-asserted-by":"crossref","first-page":"5814","DOI":"10.1016\/j.vaccine.2013.10.013","article-title":"Safety and immunogenicity of a tetravalent dengue vaccine in healthy children aged 2\u201311 years in Malaysia: a randomized, placebo-controlled, Phase III study","volume":"31","author":"Hss","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.04.050_b0070","doi-asserted-by":"crossref","first-page":"5935","DOI":"10.1016\/j.vaccine.2012.07.043","article-title":"Immunogenicity and safety of tetravalent dengue vaccine in 2\u201311 year-olds previously vaccinated against yellow fever: randomized, controlled, phase II study in Piura, Peru","volume":"30","author":"Lanata","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.04.050_b0075","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1016\/S0140-6736(12)61428-7","article-title":"Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial","volume":"380","author":"Sabchareon","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2018.04.050_b0080","doi-asserted-by":"crossref","first-page":"5127","DOI":"10.1016\/j.vaccine.2015.08.008","article-title":"Lot-to-lot consistency of a tetravalent dengue vaccine in healthy adults in Australia: a randomised study","volume":"33","author":"Torresi","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.04.050_b0085","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1097\/INF.0b013e31829b8022","article-title":"Safety and immunogenicity of a recombinant tetravalent dengue vaccine in 9\u201316 year olds: a randomized, controlled, phase II trial in Latin America","volume":"32","author":"Villar","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2018.04.050_b0090","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1086\/649916","article-title":"A novel tetravalent dengue vaccine is well tolerated and immunogenic against all 4 serotypes in flavivirus-naive adults","volume":"201","author":"Morrison","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2018.04.050_b0095","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1097\/INF.0b013e3181fe05af","article-title":"Live-attenuated tetravalent dengue vaccine in dengue-naive children, adolescents, and adults in Mexico City: randomized controlled phase 1 trial of safety and immunogenicity","volume":"30","author":"Poo","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2018.04.050_b0100","doi-asserted-by":"crossref","first-page":"724","DOI":"10.4269\/ajtmh.2011.10-0436","article-title":"Priming effect of dengue and yellow fever vaccination on the immunogenicity, infectivity, and safety of a tetravalent dengue vaccine in humans","volume":"85","author":"Qiao","year":"2011","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2018.04.050_b9000","doi-asserted-by":"crossref","first-page":"5047","DOI":"10.1016\/j.vaccine.2013.08.088","article-title":"Safety and immunogenicity of three tetravalent dengue vaccine formulations in healthy adults in the USA","volume":"31","author":"Dayan","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.04.050_b0200","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.4161\/21645515.2014.972131","article-title":"Assessment of bivalent and tetravalent dengue vaccine formulations in flavivirus-naive adults in Mexico","volume":"10","author":"Dayan","year":"2014","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2018.04.050_b0205","doi-asserted-by":"crossref","unstructured":"Tran NH, Luong CQ, Vu TQH, Forrat R, Lang J, Vu QD, et al. Safety and immunogenicity of recombinant, live attenuated tetravalent dengue vaccine (CYD- TDV) in healthy vietnamese adults and children. J Vaccine Vaccinat 2012; 3: doi: 10.4172\/2157-7560.1000162.","DOI":"10.4172\/2157-7560.1000162"},{"key":"10.1016\/j.vaccine.2018.04.050_b0210","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.4161\/hv.21224","article-title":"Immunogenicity and safety of recombinant tetravalent dengue vaccine (CYD-TDV) in individuals aged 2\u201345 y: Phase II randomized controlled trial in Singapore","volume":"8","author":"Leo","year":"2012","journal-title":"Hum Vaccine Immunother"},{"key":"10.1016\/j.vaccine.2018.04.050_b0105","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1056\/NEJMsr1604338","article-title":"Zika virus and birth defects \u2014 reviewing the evidence for causality","volume":"374","author":"Rasmussen","year":"2016","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2018.04.050_b0110","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/1471-0528.12630","article-title":"Pregnancy and childbirth outcomes among adolescent mothers: a World Health Organization multicountry study","volume":"121","author":"Ganchimeg","year":"2014","journal-title":"Br J Obstet Gynecol"},{"key":"10.1016\/j.vaccine.2018.04.050_b0115","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S0140-6736(15)01020-X","article-title":"Stillbirths: recall to action in high-income countries","volume":"387","author":"Flenady","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2018.04.050_b0120","series-title":"Sixty-Fifth World Health Assembly: Early marriages, adolescent and young pregnancies","author":"World Health Organization","year":"2012"},{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2018.04.050_b0125","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1186\/1742-4755-12-S2-S8","article-title":"Adverse maternal and perinatal outcomes in adolescent pregnancies: The Global Network's Maternal Newborn Health Registry study","volume":"12","author":"Althabe","year":"2015","journal-title":"Reprod Health"},{"key":"10.1016\/j.vaccine.2018.04.050_b0130","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.ajog.2004.10.593","article-title":"Maternal-perinatal morbidity and mortality associated with adolescent pregnancy in Latin America: Cross-sectional study","volume":"192","author":"Conde-Agudelo","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.vaccine.2018.04.050_b0135","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ejogrb.2009.06.028","article-title":"Maternal and foetal consequences of dengue fever during pregnancy","volume":"147","author":"Basurko","year":"2009","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.vaccine.2018.04.050_b0140","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/tmi.12240","article-title":"Dengue epidemics and adverse obstetrical outcomes in French Guiana: a semi-ecological study","volume":"19","author":"Hanf","year":"2014","journal-title":"Trop Med Int Health"},{"key":"10.1016\/j.vaccine.2018.04.050_b0145","doi-asserted-by":"crossref","first-page":"767","DOI":"10.3855\/jidc.908","article-title":"Dengue infections during pregnancy: case series from a tertiary care hospital in Sri Lanka","volume":"4","author":"Kariyawasam","year":"2010","journal-title":"J Infect Developing Countries"},{"key":"10.1016\/j.vaccine.2018.04.050_b0150","doi-asserted-by":"crossref","first-page":"5046091","DOI":"10.1155\/2016\/5046091","article-title":"Spectrum of maternofetal outcomes during dengue infection in pregnancy: an insight","volume":"2016","author":"Sharma","year":"2016","journal-title":"Infect Dis Obstet Gynecol"},{"key":"10.1016\/j.vaccine.2018.04.050_b0155","doi-asserted-by":"crossref","first-page":"e3226","DOI":"10.1371\/journal.pntd.0003226","article-title":"Symptomatic dengue infection during pregnancy and infant outcomes: a retrospective cohort study","volume":"8","author":"Friedman","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2018.04.050_b0160","doi-asserted-by":"crossref","unstructured":"Nascimento LB, Siqueira CM, Coelho GE, Siqueira JB, Jr. Symptomatic dengue infection during pregnancy and livebirth outcomes in Brazil, 2007-13: a retrospective observational cohort study. Lancet Infect Dis 2017.","DOI":"10.1016\/S1473-3099(17)30169-X"},{"key":"10.1016\/j.vaccine.2018.04.050_b0165","doi-asserted-by":"crossref","unstructured":"Ribeiro CF, Lopes VG, Brasil P, Silva LE, Ribeiro PH, Ugenti LC, et al. Dengue during pregnancy: association with low birth weight and prematurity. Revist Inst Med Trop Sao Paulo 2016; 58.","DOI":"10.1590\/S1678-9946201658008"},{"key":"10.1016\/j.vaccine.2018.04.050_b0170","first-page":"349","article-title":"Dengue vaccine: WHO position paper - July 2016","volume":"91","author":"World Health Organization","year":"2016","journal-title":"Releve Epidemiol Hebdomadaire"},{"key":"10.1016\/j.vaccine.2018.04.050_b0175","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1086\/648407","article-title":"Dengue virus infections and maternal antibody decay in a prospective birth cohort study of vietnamese infants","volume":"200","author":"Chau","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2018.04.050_b0180","doi-asserted-by":"crossref","first-page":"e1000171","DOI":"10.1371\/journal.pmed.1000171","article-title":"A prospective nested case-control study of Dengue in infants: rethinking and refining the antibody-dependent enhancement dengue hemorrhagic fever model","volume":"6","author":"Libraty","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.vaccine.2018.04.050_b0185","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1093\/infdis\/jiw143","article-title":"Placental Transfer of Dengue Virus (DENV)-specific antibodies and kinetics of DENV infection-enhancing activity in Brazilian infants","volume":"214","author":"Castanha","year":"2016","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2018.04.050_b0190","unstructured":"World Health Organization. Weekly epidemiological record. Meeting of the strategic advisory group of experts on immunization. Geneva: World Health Organization; 2016. p. 265\u201384."},{"key":"10.1016\/j.vaccine.2018.04.050_b0195","doi-asserted-by":"crossref","first-page":"5993","DOI":"10.1016\/j.vaccine.2016.07.006","article-title":"Global alignment of immunization safety assessment in pregnancy \u2013 The GAIA project","volume":"34","author":"Bonhoeffer","year":"2016","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18305474?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18305474?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:25:27Z","timestamp":1759400727000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X18305474"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":43,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S0264410X18305474"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.04.050","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dengue vaccination during pregnancy \u2013 An overview of clinical trials data","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.04.050","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}